Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
168 Cards in this Set
- Front
- Back
|
DRUG:
ADENOCARD (Adenosine) |
ADENOCARD 3 mg/2 ml
4 ml PFS |
|
|
ADENOCARD: DOSE & ROUTE
|
6mg rapid IVP through a large vein followed
by NS flush. If no response 12mg rapid IVP followed by NS flush. Repeat x 1 |
|
|
ADENOCARD: MECHANISM OF ACTION
|
Slows conduction time through AV node. Interrupts re-entry pathways.
|
|
|
ADENOCARD: INDICATIONS
|
Conversion of PSVT to NSR.
|
|
|
ADENOCARD: CONTRAINDICATIONS
|
2nd and 3rd AV blocks. Sick Sinus Syndrome. NOT EFFECTIVE in converting A-flutter, A-fib, or V-tach. Known hypersensitivity.
Wide complex tachycardia. |
|
|
ADENOCARD: SIDE EFFECTS
|
Hypotension, AV blocks, facial flushing, chest pain, headache, dyspnea
|
|
|
ALBUTEROL: (Proventil, Ventolin)
|
2.5mg/3ml
|
|
|
ALBUTEROL: DOSE & ROUTE
|
5mg nebulized
|
|
|
ALBUTEROL: ACTION
|
Relaxes smooth muscles of the bronchial tree and peripheral vasculature by stimulating adrenergic receptors.
|
|
|
ALBUTEROL: INDICATIONS
|
COPD
Asthma |
|
|
ALBUTEROL: CONTRAINDICATIONS
|
Known hypersensitivity.
Tachycardia caused by digitalis intoxication. Dysrhythmias assoc. with tachycardia. |
|
|
ALBUTEROL: SIDE EFFECTS
|
PALPITATIONS
ANXIETY HEADACHE NAUSEA & DIZZINESS BRONCHOSPASM |
|
|
ASPIRIN:
|
81 mg chewable tablets
|
|
|
ASPIRIN: DOSE & ROUTE
|
Four (4) 81mg/each baby ASA. Administer orally (PO). Pt. should chew then swallow each tablet.
|
|
|
ASPIRIN: ACTION
|
Helps reduce the risk of death and/or non-fatal MI in patients with a previous infarction or unstable angina pectoris. ASA has an antiplatelet effect on the blood. Blocks the formation of Thromboxane A2. Thromboxane A2 causes platelets to aggregate and arteries to constrict.
|
|
|
ASPIRIN: INDICATIONS
|
Chest pain, unstable angina, possible acute MI
|
|
|
ASPIRIN: CONTRAINDICATIONS
|
Hypersensitivity to ASA, GI bleeding
|
|
|
ASPIRIN: SIDE EFFECTS
|
Short term: GI irritation. No major side effects at low doses
|
|
|
ATIVAN
|
2 mg/1 ml
|
|
|
ATIVAN: DOSE & ROUTE
|
2mg IVP Slow over 2 minutes
Repeat X 1 |
|
|
ATIVAN: ACTION
|
benzodiazepine drug with short to medium duration of action. It has all five intrinsic benzodiazepine effects: anxiolytic, amnesic, sedative/hypnotic, anticonvulsant and muscle relaxant.
|
|
|
ATIVAN: INDICATIONS
|
Status Epileptics
|
|
|
ATIVAN: CONTRAINDICATIONS
|
Hypersensitivity to drug,
Ataxia, Acute Narrow Angle Glaucoma, Myasthenia Gravis |
|
|
ATIVAN: SIDE EFFECTS
|
Respiratory Depression,
Weakness, Dizziness |
|
|
ATROPINE
|
1 mg/ 10 ml PFS
0.1 mg/ml 1 mg/vials |
|
|
ATROPINE: DOSE & ROUTE
|
0.5mg IVP rapidly up to total dose of 3mg. May give down ETT 2mg
|
|
|
ATROPHINE: ACTION
|
Parasympatholytic: effects cause an increase rate of sinus node discharge, enhance conduction through the AV junction and an increased heart rate.
|
|
|
ATROPHINE: INDICATIONS
|
Decreased cardiac output, bradyarrhythmias with decreased BP & LOC, AV blocks, PEA.
|
|
|
ATROPHINE: CONTRAINDICATIONS
|
Hypertension, tachycardia, glaucoma
|
|
|
ATROPHINE: SIDE EFFECTS
|
Dilated pupils, dry mouth, headache, sensorium change tachycardia, flushed skins, blurred vision.
|
|
|
ATROVENT
|
(THIS IS BLANK)
|
|
|
ATROVENT: DOSE & ROUTE
|
0.5 mg nebulized
|
|
|
ATROVENT: ACTION
|
Anticholinergic Bronchodilator
|
|
|
ATROVENT: INDICATIONS
|
Brochospasm associated with COPD, including chronic Bronchitis and Emphysema
|
|
|
ATROVENT: CONTRAINDICATIONS
|
Hypersensitivity to ipratropium bromide or atropine, soy bean and peanut allergies. safe use in pediatric patients under 12 years of age have not been established.
|
|
|
ATROVENT: SIDE EFFECTS
|
Eye pain, urinary retention, tachycardia, headache, mouth dryness
|
|
|
BENADRYL Diphenhydramine
|
50 mg / ml
|
|
|
BENADRYL: DOSE & ROUTE
|
25-50mg IVP or IM
|
|
|
BENADRYL: ACTION
|
Antihistamine
Antiemetic Sedative |
|
|
BENADRYL: INDICATIONS
|
Allergic reactions
Anaphylaxis Extrapyramidal symptoms |
|
|
BENADRYL: CONTRAINDICATIONS
|
NONE
|
|
|
BENADRYL: SIDE EFFECTS
|
Drowsiness, N/V, diarrhea
Chest tightness, thickening of bronchial secretions Hypotension Headache |
|
|
CALCIUM CHLORIDE
|
10% 1g/10ml
|
|
|
CALCIUM CHLORIDE: DOSE & ROUTE
|
2-4 mg/kg IV not to exceed 1 ml per minute.
|
|
|
CALCIUM CHLORIDE: ACTION
|
Increases cardiac contractility and counteracts the effects of magnesium toxicity.
|
|
|
CALCIUM CHLORIDE: INDICATIONS
|
Acute mag toxicity, hyperkalemia, or hypocalcemia, calcium channel blocker overdose, abdominal muscle spasm associated with spider bites.
|
|
|
CALCIUM CHLORIDE: CONTRAINDICATIONS
|
Patients receiving digitalis, ventricular fibrillation.
Do not give concurrently with sodium bicarbonate. |
|
|
CALCIUM CHLORIDE: SIDE EFFECTS
|
Hypotension, arrhythmias (bradycardia and asystole).
|
|
|
CORDARONE (amidodarone)
|
150 mg/3ml
paediatric dosage: 5 mg/kg |
|
|
CORDARONE: DOSE & ROUTE
|
300mg/rapid IVP. 150mg 2nd dose for V-fib/tach.
150mg in 100cc’s over 10 min for Wide complex V-Tach with a pulse |
|
|
CORDARONE: ACTIONS
|
Class III Antiarrythmic Drug
|
|
|
CORDARONE: INDICATIONS
|
Ventricular Fibrillation
|
|
|
CORDARONE: CONTRAINDICATIONS
|
Hypersensitivity to drug
|
|
|
CORDARONE: SIDE EFFECTS
|
Hypotension, Bradycardia
|
|
|
DEXTROSE 50%
|
2.5 mg/ 50 ml
|
|
|
DEXTROSE 50% : DOSE & ROUTE
|
25gms/50ml 25-50ml slow IVP
|
|
|
DEXTROSE 50% : ACTION
|
Principal form of carbohydrate used by the body. Rapidly restores blood sugar levels to normal in hypoglycemia and acts transiently as an osmotic diuretic.
|
|
|
DEXTROSE 50%: INDICATIONS
|
Hypoglycemia
Coma of unknown origin if glucose is below 80mg/dl. |
|
|
DEXTROSE 50%: CONTRAINDICATIONS
|
CVA potential
Malnourished patients unless administered thiamine. |
|
|
DEXTROSE 50%: SIDE EFFECTS
|
Local venous irritation, Intracranial bleeding, Hyperglycemia, Diuresis. Wernicke’s Syndrome in alcoholics
|
|
|
DOPAMINE: Intropin
|
1600 mcg/ml
|
|
|
DOPAMINE: DOSE & ROUTE
|
Beta-adrenergic:
5-10mcg/kg/min. Adrenergic: 10-20mcg/kg/min. IV Drip |
|
|
DOPAMINE: ACTION
|
Act primarily on alpha1 and beta1 adrenergic receptors, systemic vascular resistance and exerting a positive inotropic effect on the heart.
|
|
|
DOPAMINE: INDICATIONS
|
Cardiogenic shock
Hemodynamic significant hypotension |
|
|
DOPAMINE: CONTRAINDICATIONS
|
Hypovolemia,hypotension secondary to uncorrected tachyarrhythmias, V-Fib, MAO inhibitors (Nardil, Marplan, Eutonyl, Parnate)
Pheochromocytoma |
|
|
DOPAMINE: SIDE EFFECTS
|
Dose-related tachydysrhythmias
Headache Angina pain Hypertension N/V |
|
|
EPINEPHRINE (Adrenalin)
1:1,000 |
1:1,000
1 mg/ml ampule or 30 mg MDV 0.15 mg PFS 0.3 mg PFS |
|
|
EPINEPHRINE: DOSE & ROUTE
1:1,000 |
0.3-0.5mg IM (anaphylaxis, asthma)
ARREST: 1mg Aerosolized: 0.5mg in 5cc’s Saline Asthma/COPD Drip: 2-10mcg/min IV Drip Bradycardia |
|
|
EPINEPHRINE: ACTION
1:1,000 |
Beta1 effects:
Increases automaticity, conductivity, and contractility. Beta2 effects: Bronchodilation Alpha Effects: Vasoconstriction |
|
|
EPINEPHRINE: INDICATIONS
1:1,000 |
Anaphylaxis
Asthma Cardiac Arrest |
|
|
EPINEPHRINE: CONTRAINDICATIONS
1:1,000 |
History of heart disease
Age > 50 yrs. or heart rate > 130, or SBP > 160 mmHg Patient taking: MAO inhibitors Tricyclic antidepressants |
|
|
EPINEPHRINE: SIDE EFFECTS
1:1,000 |
Ventricular irritability
Hypertension Tachyarrhythmias Restlessness Anxiety |
|
|
EPINEPHRINE
1:10,000 |
1:10,000
1mg/10 ml PFS Aerosolized EPI 5 ml/ 1:10,000 |
|
|
EPINEPHRINE: DOSE & ROUTE
1:10,000 |
1mg IVP/ET every 3-5 min
0.5mg Nebulized |
|
|
EPINEPHRINE: ACTION
1:10,000 |
Beta1 effects:
Increases automaticity, conductivity, and contractility. Beta2 effects: Bronchodilation Alpha Effects: Vasoconstriction |
|
|
EPINEPHRINE: INDICATIONS
1:10,000 |
Cardiac Arrest
Asystole PEA Vfib Asthma |
|
|
EPINEPHRINE: CONTRAINDICATIONS
1:10,000 |
Do not add directly to a bicarbonate solution.
Patient taking: MAO inhibitors Tricyclic antidepressants except in arrest |
|
|
EPINEPHRINE: SIDE EFFECTS
1:10,000 |
Ventricular irritability
Hypertension Tachyarrhythmias Restlessness Anxiety |
|
|
ETOMIDATE
|
20 mg/ 10 ml
|
|
|
ETOMIDATE: DOSE & ROUTE
|
20mg /10 ml 0.3 mg/kg
|
|
|
ETOMIDATE: ACTION
|
Etomidate is highly protein bound in blood plasma and is metabolised by hepatic and plasma esterases to inactive products. It has a redistribution half-life of 2–5 minutes and an elimination half-life of 68–75 min.
|
|
|
ETOMIDATE: INDICATIONS
|
Sedation Assisted Intubation
|
|
|
ETOMIDATE: CONTRAINDICATIONS
|
Hypersensitivity to drug
|
|
|
ETOMIDATE: SIDE EFFECTS
|
EXCITATORY, PHENOMENA, AND EPILEPTIFORM MOVEMENTSS.
|
|
|
FENTANYL
|
100 mcg/2cc
|
|
|
FENTANYL: DOSE & ROUTE
|
100mcg/2cc 1mcg/kg
Contact Medical Control for 2nd dose. SAI: 2mcg/kg 0.5mcg/kg for pts. > 70yrs. |
|
|
FENTANYL: ACTION
|
Rapid-acting opioid (or synthetic opiate), which depresses central nervous system and respiratory function. It is one of the most powerful opioid analgesics, with a potency approximately 80 times that of morphine
|
|
|
FENTANYL: INDICATIONS
|
Pain Management,
|
|
|
FENTANYL: CONTRAINDICATIONS
|
Hypersensitivity to fentanyl or any component of the formulation; increased intracranial pressure; severe respiratory disease or depression including acute asthma (unless patient is mechanically ventilated); paralytic ileus; severe liver or renal insufficiency;
|
|
|
FENTANYL: SIDE EFFECT
|
Hypotension, N&V, CNS Depression, Chest Wall Rigidity,
|
|
|
GLUCAGON
|
DILUTE 1 unit of powder 1 ml of its own diluting solution
|
|
|
GLUCAGON: DOSE & ROUTE
|
1mg IM, SQ
|
|
|
GLUCAGON: ACTION
|
Protein secreted by the alpha cells of the pancreas. Elevates blood glucose by breaking down glycogen (liver) into glucose.
|
|
|
GLUCAGON: INDICATIONS
|
Hypoglycemia <80mg/dl
Beta Blocker overdose Calcium channel blocker overdose |
|
|
GLUCAGON: CONTRAINDICATIONS
|
Hypersensitivity
|
|
|
GLUCAGON: SIDE EFFECTS
|
hypersensitivity reaction, N/V hypertension, hypotension tachycardia
|
|
|
GLUCOSE (ORAL)
|
24g oral gel
|
|
|
GLUCOSE: DOSE & ROUTE
|
1 tube (24g) PO.
|
|
|
GLUCOSE: ACTION
|
Provides carbohydrates with approximately 96 calories and prevents hypoglycemia.
|
|
|
GLUCOSE: INDICATION
|
Hypoglycemia <80mg/dl
|
|
|
GLUCOSE: CONTRAINDICATIONS
|
AMS with inability to protect airway or swallow.
|
|
|
GLUCOSE: SIDE EFFECTS
|
NONE
|
|
|
LIDOCAINE
|
100 mg/5ml PFS
2 gm/500 ml |
|
|
LIDOCAINE: DOSE & ROUTE
|
LIDOCAINE
100mg/5ml PFS 2gm/500ml 1-1.5mg/kg IVP 2nd dose 0.5-0.75mg/kg 2-4mg/min. IV Drip Antiarrhythmic Decreases ventricular excitability Frequent or multifocal PVC’s in AMI V-fib V-tach Hypersensitivity to Caines and Amides Intraventricular blocks idoventricular or escape rhythms. CHF, bradycardia CNS depression Anxiety Irritability Sz (elderly) Excessive doses can result in coma and death |
|
|
LIDOCAINE: ACTION
|
Antiarrhythmic
Decreases ventricular excitability |
|
|
LIDOCAINE: INDICATIONS
|
Frequent or multifocal PVC’s in AMI
V-fib V-tach |
|
|
LIDOCAINE: CONTRAINDICATIONS
|
Hypersensitivity to Caines and Amides
Intraventricular blocks idoventricular or escape rhythms. CHF, bradycardia |
|
|
LIDOCAINE: SIDE EFFECTS
|
CNS depression
Anxiety Irritability Sz (elderly) Excessive doses can result in coma and death |
|
|
MAG SULFATE
|
5mg/10 ml vial
|
|
|
MAG SULFATE: DOSE & ROUTE
|
OB:
Ecclamptic - 2-4 g SLOW IV over 5 minutes. VF/Pulseless VT: 1-2 g diluted with 10 ml NS over 1-2 minutes. Torsades: 2g diluted in 100 ml NS given 1 g/min. Asthma: 2g diluted in 100cc NS over 20 minutes |
|
|
MAG SULFATE: ACTION
|
CNS depressant, anticonvulsant, and antiarrhythmic.
|
|
|
MAG SULFATE: INDICATIONS
|
OB: Pregnancy toxemia.
Cardiac: severe, refractory VF/pulseless VT, torsades de pointes. |
|
|
MAG SULFATE: CONTRAINDICATIONS
|
Heart blocks, shock, routine dialysis patients, patients receiving digitalis, and hypocalcemia.
|
|
|
MAG SULFATE: SIDE EFFECTS
|
Flushing, sweating, bradycardia, deep tendon reflexes, drowsiness, respiratory depression, arrhythmias, hypotension, hypothermia, itching, and rash.
|
|
|
MORPHINE SULFATE
|
2mg/l
|
|
|
MORPHINE SULFATE: DOSE & ROUTE
|
2-4mg/slow IVP initially or per physician order
|
|
|
MORPHINE SULFATE: ACTION
|
Narcotic:
pain perception & anxiety venous return (preload) |
|
|
MORPHINE SULFATE: INDICATIONS
|
Chest pain with AMI
Moderate - severe pain Pulmonary edema |
|
|
MORPHINE SULFATE: CONTRAINDICATIONS
|
Head injury
Undiagnosed abd pain (relative) Hypotension Respiratory depression |
|
|
MORPHINE SULFATE: SIDE EFFECTS
|
Bradycardia
LOC Respiratory depression N/V |
|
|
NARCAN ( naloxsone)
|
1mg/ml
|
|
|
NARCAN: DOSE & ROUTE
|
1mg/ml 0.4-2mg IVP, IM, SQ, ETT
|
|
|
NARCAN: ACTION
|
Reverses the effects of opiates including respiratory depression, sedation and hypotension
|
|
|
NARCAN: INDICATIONS
|
Narcotic overdose
Coma of unknown etiology |
|
|
NARCAN: CONTRAINDICATIONS
|
Known hypersensitivity
Caution with patients having narcotic addiction |
|
|
NARCAN: SIDE EFFECTS
|
N/V and ventricular arrhythmias if given too rapidly
Withdrawal symptoms |
|
|
NITRO STAT
|
0.4 mg (1/150 gr)
|
|
|
NITRO STAT: DOSE & ROUTE
|
0.4mg SL every 5 min
for total of (3) tabs |
|
|
NITRO STAT: ACTION
|
Relaxes vascular smooth muscle, which results in vasodilatation. Relaxes coronary arteries (dilation) which improves coronary flow
|
|
|
NITRO STAT: INDICATIONS
|
AMI
Angina Pulmonary edema |
|
|
NITRO STAT: CONTRAINDICATIONS
|
Increased intracranial pressure
Glaucoma Hypotension Shock Hypertension with neuro deficits Current usage of erectile dysfunction drugs |
|
|
NITRO STAT: SIDE EFFECTS
|
Transient:
Headache Hypotension Dizziness Weakness Dry mouth |
|
|
SODIUM BICARBONATE
|
8.4%%
50 mEq / 50 ml PFS |
|
|
SODIUM BICARBONATE: DOSE & ROUTE
|
1mEq/kg IVP; repeat with
0.5mEq/kg every 10 min. 50meq IV – Med Control with Tricyclic Antidepressant Drugs Overdoses. |
|
|
SODIUM BICARBONATE: ACTION
|
As a buffer it reacts with hydrogen ions to form carbon dioxide. the plasma concentration of bicarbonate causes blood pH to rise.
|
|
|
SODIUM BICARBONATE: INDICATIONS
|
Intubated with long arrest interval.
ROSC after long arrest interval. Tricyclic antidepressant overdose. Alkalinization for treatment of specific intoxications. |
|
|
SODIUM BICARBONATE: CONTRAINDICATIONS
|
Metobolic or respiratory alkalosis.
Hypocalcemia Hypokalemia Careful with patients having cardiac, liver, or kidney disease. |
|
|
SODIUM BICARBONATE: SIDE EFFECTS
|
Metabolic alkalosis
Hypoxia Increased tissue acidosis. |
|
|
SOLU-MEDROL
|
125mg
|
|
|
SOLU- MEDROL: DOSE & ROUTE
|
SOLU-MEDROL
125mg IVP over 2 minutes or infusion. Pediatrics 1mg/kg max 125mg |
|
|
SOLU-MEDROL: ACTION
|
Potent anti-inflammatory steroid with greater potency than prednisone and less tendency to induce sodium and water retention.
|
|
|
SOLU-MEDROL: INDICATIONS
|
Control of severe or incapacitating allergic conditions such as asthma, hypersensitivity reactions, and acute noninfectious laryngeal edema
|
|
|
SOLU-MEDROL: CONTRAINDICATIONS
|
Known Hypersensitivity
|
|
|
SOLU-MEDROL: SIDE EFFECTS
|
Increased appetite, weight gain and fluid retention; Increased blood sugar and sugar in the urine; Irritability and mood/behavior changes; Less resistance to infection and longer time for healing; Increased Blood Pressure.
|
|
|
THIAMINE
|
100mg/ml in 2 ml
|
|
|
THIAMINE: DOSE & ROUTE
|
100mg/ml in 2ml 100mg slow IVP or IM
|
|
|
THIAMINE: ACTION
|
A B1 vitamin that combines with ATP and forms an coenzyme used in carbohydrate metabolism. The brain is extremely sensitive to Thiamine deficiency.
|
|
|
THIAMINE: INDICATIONS
|
Coma of unknown origin (before D50 administration)
Delirium tremens Prior history of alcoholism, malnourishment, chronic disease state. |
|
|
THIAMINE: CONTRAINDICATIONS
|
No significant ones
|
|
|
THIAMINE: SIDE EFFECTS
|
Hypotension
Anxiety Diaphoresis N/V |
|
|
TYLENOL (AETAMINOPHEN)
|
(blank)
|
|
|
TYLENOL: DOSE & ROUTE
|
(Acetaminophen) 15mg/kg orally
|
|
|
TYLENOL: ACTION
|
Fever reduction/pain reduction
|
|
|
TYLENOL: INDICATIONS
|
Pediatric patients with fever greater than 102 degrees
|
|
|
TYLENOL: CONTRAINDICATIONSW
|
Known Hypersensitivity
|
|
|
TYLENOL: SIDE EFFECTS
|
Liver damage in large doses
|
|
|
VERSED (MIDOZALAM HC1)
|
1 mg/ml
|
|
|
VERSED: DOSE & ROUTE
|
2.5-5.0mg slow IVP over
2-3 minutes or IM. May repeat in small increments up to 5mg. 10 mg IVP for emergency endotracheal intubation |
|
|
VERSED: ACTION
|
Short acting benzodiazepine CNS depressant.
|
|
|
VERSED: INDICATIONS
|
Status Seizures (If Ativan not possible)
Conscious sedation Emergency intubation |
|
|
VERSED: ; CONTRAINDICATIONS
|
Known hypersensitivity
Alcohol intoxication Glaucoma Shock Coma Depressed V/S Concomitant use of barbiturates, alcohol, narcotics or other CNS depressants. |
|
|
VERSED: SIDE EFFECT
|
Hiccough
Cough Oversedation N/V Headache Blurred vision Hypotension Respiratory depression Respiratory arrest |
|
|
ZOFRAN ( ONDANSETRON)
|
4mg/2ml
|
|
|
ZOFRAN: DOSE & ROUTE
|
4mg slow IVP
Pediatrics 0.1mg/kg max 4mg. Intramuscular and intranasal routes can be considered. |
|
|
ZOFRAN: ACTION
|
Serotonin 5-HT3 type receptor antagonist. Inhibits the sensation of nausea by blocking Serotonin uptake.
|
|
|
ZOFRAN: INDICATIONS
|
Moderate to severe nausea/vomiting
|
|
|
ZOFRAN: CONTRAINDICATIONS
|
Known hypersensitivity
|
|
|
ZOFRAN: SIDE EFFECTS
|
Flushing, burning, pain at the site of injection may be noted along with hiccups, dizziness, urticaria, dystonic reactions, blurred vision and dry mouth.
|
